Infographic
Hey big vendor... Is bioprocessing consolidation good for the end-user?
Price hikes and lack of innovation, or better buying power and end-to-end services? Experts are split on supplier M&A and its effect on biomanufacturers.
Archives for April 18, 2017
Synpromics announces £5.2M British investment in gene therapy tech
Scottish synthetic biology firm Synpromics has received £5.2M ($6.6M) to enhance its synthetic promoter design technology used in gene therapy development.
1st Stem Cell Community day in Germany
For stem cells 'the process is the product,' says Pluristem
Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.